StockNews.com has recently covered BIOLASE (NASDAQ:BIOL) and set a “sell” rating on the medical technology company’s shares, while Lake Street Capital has reissued a “buy” rating on BIOLASE shares. BIOLASE, Inc. is a medical device company that develops, manufactures, and sells laser systems in dentistry and medicine. The company’s Waterlase systems use a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. Additionally, several institutional investors have made changes to their positions in the company, including Citadel Advisors LLC, Renaissance Technologies LLC, Capital Wealth Alliance LLC, Essex Investment Management Co. LLC, and Perkins Capital Management Inc.
StockNews.com has recently covered BIOLASE (NASDAQ:BIOL) and set a “sell” rating on the medical technology company’s shares. On the other hand, Lake Street Capital has reissued a “buy” rating on BIOLASE shares in a research note. As of Wednesday, BIOLASE’s stock opened at $0.39, with a 52-week low of $0.30 and a 52-week high of $9.24. The company has a debt-to-equity ratio of 0.92, a quick ratio of 1.27, and a current ratio of 2.46. Moreover, BIOLASE has a market cap of $3.03 million, a price-to-earnings ratio of -0.11, and a beta of 1.40.
Several institutional investors have made changes to their positions in the company. Citadel Advisors LLC purchased a new stake in BIOLASE’s shares valued at $118,000. Renaissance Technologies LLC increased its position in BIOLASE shares by 128.5% in the 4th quarter. Capital Wealth Alliance LLC bought a new stake in BIOLASE’s shares valued at $51,000, while Essex Investment Management Co. LLC increased its position in BIOLASE shares by 62.3% in the 3rd quarter. Finally, Perkins Capital Management Inc. increased its position in BIOLASE shares by 11.6% in the 3rd quarter. Institutional investors now own 20.68% of the company’s stock.
BIOLASE, Inc. is a medical device company that develops, manufactures, and sells laser systems in dentistry and medicine. The company operates through its Waterlase (all-tissue) and Diode (soft-tissue) systems products. BIOLASE’s Waterlase systems use a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue.
To receive the latest news and ratings for BIOLASE and related companies, enter your email address below to subscribe to MarketBeat.com’s FREE daily email newsletter.
Don’t miss interesting posts on Famousbio
